CELU · NASDAQ
Celularity (CELU) Stock Price & Fundamentals
Celularity (CELU) closed at $868.82 on Oct 9, 2026, down 0.43% from the previous close of $872.61.
Share price, past year
1Y +11.46%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $868.82 |
| Sep 30, 2026 | $877.31 |
| Aug 31, 2026 | $876.85 |
| Jul 31, 2026 | $876.12 |
| Jun 30, 2026 | $822.31 |
| May 29, 2026 | $835.41 |
| Apr 30, 2026 | $900.72 |
| Mar 31, 2026 | $925.26 |
| Feb 27, 2026 | $907.61 |
| Jan 30, 2026 | $865.18 |
| Dec 31, 2025 | $839.51 |
| Nov 28, 2025 | $818.27 |
| Oct 31, 2025 | $769.29 |
Key statistics
- Market cap
- $25.35B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.73
- Revenue (TTM)
- $18.97M
- Net income (TTM)
- −$71.09M
- Shares outstanding
- 29.2M
- Dividend yield
- —
- 52-week range
- $753.64 – $934.48
Celularity's market cap is $25.35B, based on a share price of $868.82 and 29.2M shares outstanding as of Mar 31, 2026.
Financials
Celularity reported revenue of $26.55M for fiscal 2025, down 51.03% from fiscal 2024.
Celularity reported a net loss of $91.72M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $26.55M | −51.0% | −$91.72M | −345.5% | −$3.59 | — |
| FY2024ended Dec 31, 2024 | $54.22M | +138.1% | −$57.89M | −106.8% | −$2.64 | −$6.56M |
| FY2023ended Dec 31, 2023 | $22.77M | +26.7% | −$196.30M | −862.0% | −$11.02 | −$39.73M |
| FY2022ended Dec 31, 2022 | $17.98M | −15.8% | $14.19M | 79.0% | $0.95 | −$143.11M |
| FY2021ended Dec 31, 2021 | $21.34M | +49.4% | −$100.12M | −469.3% | −$1.49 | −$116.30M |
| FY2020ended Dec 31, 2020 | $14.28M | — | −$208.23M | −1,458.4% | −$11.31 | −$91.03M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $3.85M | $874.00K | $0.02 |
| Q4 FY2025ended Dec 31, 2025 | $4.10M | −$24.36M | −$0.85 |
| Q3 FY2025ended Sep 30, 2025 | $5.28M | −$23.08M | −$0.88 |
| Q2 FY2025ended Jun 30, 2025 | $5.74M | −$24.52M | −$1.02 |
| Q1 FY2025ended Mar 31, 2025 | $11.43M | −$19.75M | −$0.84 |
| Q4 FY2024ended Dec 31, 2024 | $18.13M | −$13.29M | −$0.58 |
| Q3 FY2024ended Sep 30, 2024 | $9.30M | −$16.10M | −$0.73 |
| Q2 FY2024ended Jun 30, 2024 | $12.11M | −$6.49M | −$0.30 |
Company profile
- Name
- Celularity Inc
- Ticker
- CELU
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 170 Park Ave, Florham Park, NJ 07932
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001752828
Recent SEC filings
- Sep 29, 2026
- Sep 29, 2026
- Sep 28, 2026
- Sep 14, 2026
- Aug 7, 2026
- Jul 29, 2026
- Jun 30, 2026
- Jun 25, 2026
Frequently asked questions
What is Celularity's stock price?
Celularity (CELU) closed at $868.82 on Oct 9, 2026, down 0.43% from the previous close of $872.61.
What is Celularity's market cap?
Celularity's market cap is $25.35B, based on a share price of $868.82 and 29.2M shares outstanding as of Mar 31, 2026.
How much revenue does Celularity make?
Celularity reported revenue of $26.55M for fiscal 2025, down 51.03% from fiscal 2024.
Does Celularity pay a dividend?
Celularity's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Celularity Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures